A prospective, non-randomized, no placebo-controlled, phase Ib clinical trial to study the safety of the adipose derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis

被引：0
|
作者：
Argyris Tzouvelekis
Vassilis Paspaliaris
George Koliakos
Paschalis Ntolios
Evangelos Bouros
Anastasia Oikonomou
Athanassios Zissimopoulos
Nikolaos Boussios
Brian Dardzinski
Dimitrios Gritzalis
Antonis Antoniadis
Marios Froudarakis
George Kolios
Demosthenes Bouros
机构：
[1] Democritus University of Thrace,Department of Pneumonology, Medical School
[2] Adistem Ltd,Laboratory of Pharmacology, Medical School
[3] Hellenic National research foundation stem cell bank,Department of Radiology, Medical School
[4] Biohellenika SA,Department of Nuclear Medicine, Medical School
[5] Democritus University of Thrace,Department of Pneumonology
[6] Democritus University of Thrace,Department of Pneumonology
[7] Democritus University of Thrace,undefined
[8] Iaso General Hospital,undefined
[9] General Hospital of Serres,undefined
[10] University Hospital of Alexandroupolis,undefined
[11] Democritus University of Thrace,undefined
来源：
Journal of Translational Medicine | / 11卷
关键词：
Adipose derived stromal cells; Mesenchymal stem cells; Idiopathic pulmonary fibrosis; Safety; Clinical trial; Stromal vascular fraction;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] A phase 1b study of placenta-derived mesenchymal stromal cells in patients with idiopathic pulmonary fibrosis
    Chambers, Daniel C.
    Enever, Debra
    Ilic, Nina
    Sparks, Lisa
    Whitelaw, Kylie
    Ayres, John
    Yerkovich, Stephanie T.
    Khalil, Dalia
    Atkinson, Kerry M.
    Hopkins, Peter M. A.
    RESPIROLOGY, 2014, 19 (07) : 1013 - 1018
  • [22] The RIFF Study (Cohort A): A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial of Lebrikizumab as Monotherapy in Patients with Idiopathic Pulmonary Fibrosis
    Swigris, J. J.
    Ogura, T.
    Scholand, M.
    Glaspole, I.
    Maher, T. M.
    Kardatzke, D.
    Kaminski, J.
    Castro, M.
    Owen, R.
    Neighbors, M.
    Belloni, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [23] Clinical Outcome of Minimally Manipulated, Mechanically Isolated Autologous Adipose Tissue-Derived Stromal Vascular Fraction (Sahaj Therapy®) in Knee Osteoarthritis—Randomized Controlled Trial
    Vinay Tantuway
    Wayne Thomas
    Mittal B. Parikh
    Raj Sharma
    Naveen Jeyaraman
    Madhan Jeyaraman
    Indian Journal of Orthopaedics, 2023, 57 : 1646 - 1658
  • [24] Adipose derived stromal cells for treatment of patients with chronic ischemic heart disease (MyStromalCell Trial): a randomised placebo controlled study
    Qayyum, A. A.
    Mathiasen, A. B.
    Mygind, N. D.
    Joergensen, E.
    Helqvist, S.
    Elberg, J. J.
    Kofoed, K. F.
    Vejlstrup, N. G.
    Soerensen, M. H.
    Ekblond, A.
    Kastrup, J.
    EUROPEAN HEART JOURNAL, 2016, 37 : 1020 - 1020
  • [25] LEBRIKIZUMAB IDIOPATHIC PULMONARY FIBROSIS TRIAL: A PHASE II RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED STUDY TO ASSESS EFFICACY AND SAFETY (RIFF)
    Scalori, A.
    Belloni, P.
    Ackrill, A.
    Kapugampola, L.
    Doyle, R.
    Kaminski, J.
    RESPIROLOGY, 2014, 19 : 145 - 145
  • [26] The investigation of the efficacy and safety of stromal vascular fraction in the treatment of nanofat-treated acne scar: a randomized blinded controlled clinical trial
    Behrangi, Elham
    Moradi, Sepideh
    Ghassemi, Mohammadreza
    Goodarzi, Azadeh
    Hanifnia, Amirreza
    Zare, Sona
    Nouri, Maryam
    Dehghani, Abbas
    Seifadini, Azadeh
    Nilforoushzadeh, Mohammad Ali
    Roohaninasab, Masoumeh
    STEM CELL RESEARCH & THERAPY, 2022, 13 (01)
  • [27] The investigation of the efficacy and safety of stromal vascular fraction in the treatment of nanofat-treated acne scar: a randomized blinded controlled clinical trial
    Elham Behrangi
    Sepideh Moradi
    Mohammadreza Ghassemi
    Azadeh Goodarzi
    Amirreza Hanifnia
    Sona Zare
    Maryam Nouri
    Abbas Dehghani
    Azadeh Seifadini
    Mohammad Ali Nilforoushzadeh
    Masoumeh Roohaninasab
    Stem Cell Research & Therapy, 13
  • [28] Efficacy of stromal vascular fraction for knee osteoarthritis: A prospective, single-centre, non-randomized study with 2 years follow-up
    Jeyaraman, Madhan
    Jeyaraman, Naveen
    Jayakumar, Tarun
    Ramasubramanian, Swaminathan
    Ranjan, Rajni
    Jha, Saurabh Kumar
    Gupta, Ashim
    WORLD JOURNAL OF ORTHOPEDICS, 2024, 15 (05): : 457 - 468
  • [29] Prospective phase 1 open clinical trial to study the safety of adipose derived mesenchymal stem cells (ADMSCs) in COPD and combined pulmonary fibrosis and emphysema (CPFE)
    Tzilas, Vassilios
    Bouros, Evangelos
    Fourla, Danae
    Zisimopoulos, Athanasios
    Papadopoulos, Nikolaos
    Koliakos, George
    Kolios, George
    Pneumatikos, Ioannis
    Aidinis, Vassilis
    Tzouvelekis, Agyris
    Bouros, Demosthenes
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [30] Outcome of safety and efficacy of allogeneic mesenchymal stromal cell derived from umbilical cord for the treatment of osteoarthritis in a randomized blinded placebo-controlled trial
    Shah, Kiran
    Sumer, Huseyin
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7
12345